APOLOGIX Trademark

Trademark Overview

On Wednesday, July 22, 2020, a trademark application was filed for APOLOGIX with the United States Patent and Trademark Office. The USPTO has given the APOLOGIX trademark a serial number of 90067387. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, July 15, 2024. This trademark is owned by ALZHEON, INC.. The APOLOGIX trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating neurological, neurodegenerative and psychiatric diseases and disorders, pharmaceutical preparations for treating conditions caused by cognitive impairment and brain injuries
apologix

General Information

Serial Number90067387
Word MarkAPOLOGIX
Filing DateWednesday, July 22, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, July 15, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 15, 2020

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating neurological, neurodegenerative and psychiatric diseases and disorders, pharmaceutical preparations for treating conditions caused by cognitive impairment and brain injuries

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 19, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameALZHEON, INC.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressFRAMINGHAM, MA 01701
Party NameALZHEON, INC.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressFRAMINGHAM, MA 01701

Trademark Events

Event DateEvent Description
Saturday, July 25, 2020NEW APPLICATION ENTERED
Wednesday, August 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, November 5, 2020ASSIGNED TO EXAMINER
Friday, November 6, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, November 25, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 15, 2020PUBLISHED FOR OPPOSITION
Tuesday, December 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Wednesday, January 6, 2021EXTENSION OF TIME TO OPPOSE RECEIVED
Monday, April 26, 2021EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED
Tuesday, June 8, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, December 6, 2021SOU TEAS EXTENSION RECEIVED
Monday, December 6, 2021SOU EXTENSION 1 FILED
Monday, December 6, 2021SOU EXTENSION 1 GRANTED
Wednesday, December 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sunday, June 5, 2022SOU TEAS EXTENSION RECEIVED
Sunday, June 5, 2022SOU EXTENSION 2 FILED
Sunday, June 5, 2022SOU EXTENSION 2 GRANTED
Tuesday, June 7, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 8, 2022SOU TEAS EXTENSION RECEIVED
Thursday, December 8, 2022SOU EXTENSION 3 FILED
Thursday, December 8, 2022SOU EXTENSION 3 GRANTED
Saturday, December 10, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, June 8, 2023SOU TEAS EXTENSION RECEIVED
Thursday, June 8, 2023SOU EXTENSION 4 FILED
Thursday, June 8, 2023SOU EXTENSION 4 GRANTED
Saturday, June 10, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 8, 2023SOU TEAS EXTENSION RECEIVED
Friday, December 8, 2023SOU EXTENSION 5 FILED
Friday, December 22, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Friday, December 22, 2023SOU EXTENSION 5 GRANTED
Saturday, December 23, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, July 15, 2024ABANDONMENT - NO USE STATEMENT FILED
Monday, July 15, 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Related Keywords

apologix pharmaceutical treating preparations cognitive impairment injuries caused brain diseases neurological